Project Details
Projekt Print View

Molecular imaging with innovative and approved tracers to resolve tumor heterogeneity and predict therapeutic outcome (B02)

Subject Area Nuclear Medicine, Radiotherapy, Radiobiology
Term from 2009 to 2021
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 68647618
 
Molecular imaging techniques providing a better representation of the tumor-mass and resolving tumor heterogeneity are in urgent demand to improve the poor prognosis of brain tumor (glioma) patients. Therefore, we investigate combinatorial imaging by PET, MRI and optoacoustic coupling in preclinical models faithfully recapitulating distinct genetic and pathological subsets of gliomas. Our approach will delineate the individual strength of each imaging-procedure in localizing pathologically relevant tumor-areas and will provide new information for treatment-planning and -monitoring. In particular we use imaging tracers indicating invasive, angiogenic and metabolically conspicuous tumor-fields and determine the impact of blood-brain barrier integrity in our imaging modalities.
DFG Programme Collaborative Research Centres
 
 

Additional Information

Textvergrößerung und Kontrastanpassung